Early Access — free while we kick the tires
EdgarHawk

Maharajh Ramsaran

EVP and General Counsel

Officer
2 filings analyzed · 1 company · Latest 2026-02-23

Companies

Company Buys Sells Direction
RTX Corp RTX 0 6 Net selling

Activity

February 2026
2026-02-23 RTX Corp RTX
medium
Sell
15,124 shares
$3,095,124
Significance 4/10

RTX EVP General Counsel Ramsaran sold 15,124 shares at $204.65 (total $3.1M), reducing holdings by 53.4% to 13,184 shares

Maharajh Ramsaran sold 15,124 shares of RTX at $204.65 on 2026-02-19, a substantial reduction representing 53.4% of his pre-transaction holdings. The sale occurred near the 52-week high of $205.41, with the stock trading at $201.92 currently. Examining his same-ticker history at RTX, Ramsaran's prior 2 sales (both on 2025-02-25) yielded 30-day returns of +5.2% and 90-day returns of +4.4%, meaning the stock rose after both sales—neither was well-timed. His cross-ticker track record shows 2 prior sells with an average 90-day return of +4.4% and a 0.00% well-timed rate, further indicating his recent sales across holdings have not preceded stock declines. The significant reduction in RTX holdings warrants monitoring for potential future capital allocation or liquidity decisions.

February 2025
2025-02-27 RTX Corp RTX
high
Sell
19,431 shares
$2,464,253
Significance 6/10

RTX EVP & General Counsel Ramsaran sold 19,431 shares for $2.5M at blended price $126.82; post-transaction holdings 14,646 shares (-57.0%)

Maharajh Ramsaran, EVP and General Counsel of RTX, executed 2 separate sales totaling 19,431 shares for $2,464,252.88 at a blended average price of $126.82. This represents a substantial reduction in his holdings—a net change of -57.0% relative to pre-transaction holdings of 34,077 shares. The current price of $130.52 is at the 52-week high (+0.0% from the upper range), suggesting the shares sold were disposed of near peak valuations. With RTX fundamentals showing strong revenue growth of +17.2% year-over-year and net income of $1,472,000,000.00 in the latest quarter, the sale does not coincide with operational deterioration. The magnitude of this reduction—more than half the position—warrants investor attention to understand the executive's underlying rationale.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access